HITLAB’s Welcomes New Member to Breakthrough Alliance Board

HITLAB announced today that Pat Verduin, Chief Technology Officer,  Colgate-Palmolive Company has joined the Breakthrough Alliance (BTA) board. Colgate-Palmolive is a leading consumer goods company, guided by its purpose as a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet.

The BTA is a digital health consortium of executive leaders from across life science, pharmaceutical, academic medical institutions and healthcare providers including New York City Economic Development Corporation, Merck Global Health Innovation, Johnson & Johnson,  Fund LLC, BDO, Atlas Venture, StartUp Health, CATALAIZE, Consummate Capital,  EdgeOne Medical, Esplanade Ventures, FFF, and Northwell Health, all committed to improving health outcomes and care delivery through verified emerging technologies. The board is chaired by Bill Taranto, the CEO of the Merck Global Innovation Fund.

The BTA board meets every quarter. All members have the benefits of:

• Setting priorities to guide the development of research studies for selected digital health technologies

• Receiving exclusive access to investment and partnership opportunities with the latest digital health tech under development

• Gaining insights into the future of digital health by seeing the results of the verified and risk-reduced studies.

“I am personally delighted to welcome Pat as a new board member,” said Bill Taranto, CEO of Merck Global Health Innovation Fund and Chair of HITLAB BTA. “With her strong technical expertise coupled with her experience working in health and wellness, she is an ideal addition to the board. I look forward to working with her.”

“The work HITLAB is doing in the healthcare space reflects Colgate-Palmolive’s purpose to reimagine a healthier future for all. I am honored and excited to serve on the BTA board,” said Pat Verduin, Chief Technology Officer, Colgate-Palmolive. “I look forward to working with HITLAB and the board to further their mission and goals.”

ABOUT HITLAB

Established in 1998, HITLAB is a leading evidence-based, healthcare innovation lab specializing in the delivery of world-class digital health research and education. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.

About HITLAB Breakthrough Alliance

HITLAB Breakthrough Alliance is an accelerator that helps early-stage startups conduct rapid pilot studies to test their products and move closer to market. Selected startups have their technologies tested in pilot studies with clinical partners and patients, gathering the data needed to accelerate their concepts. To source startups, Breakthrough holds open innovation competitions and networking events that bring together the digital health and investment ecosystem.

Breakthrough is membership-based and board members represent the best organizations in healthcare.